WebMd: ACETYL - L - CARNITINE (including other names)
~~~~~~~~~~~~~~~~~~~~
This study is not yet open for participant recruitment.
Verified April 2012 by National Cancer Institute (NCI)
First Received on December 14, 2011.
Last Updated on April 17, 2012
History of Changes
Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy - Full Text View - ClinicalTrials.gov
Purpose
RATIONALE:
Acetyl-L-carnitine hydrochloride may prevent or lessen peripheral
neuropathy caused by chemotherapy. It is not yet known whether
acetyl-L-carnitine hydrochloride is more effective compared to a placebo
in preventing peripheral neuropathy caused by chemotherapy.
PURPOSE: This randomized
phase III trial studies how well acetyl-L-carnitine hydrochloride works
compared to a placebo in preventing peripheral neuropathy in patients
with recurrent ovarian epithelial cancer, primary peritoneal cancer, or fallopian tube cancer undergoing chemotherapy.
